0001209191-18-002812.txt : 20180108
0001209191-18-002812.hdr.sgml : 20180108
20180108202613
ACCESSION NUMBER: 0001209191-18-002812
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180104
FILED AS OF DATE: 20180108
DATE AS OF CHANGE: 20180108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BALTIMORE DAVID
CENTRAL INDEX KEY: 0001185858
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36561
FILM NUMBER: 18517672
MAIL ADDRESS:
STREET 1: AMGEN INC.
STREET 2: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320-1799
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Immune Design Corp.
CENTRAL INDEX KEY: 0001437786
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262007174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1616 EASTLAKE AVE. E
STREET 2: SUITE 310
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: (206) 682-0645
MAIL ADDRESS:
STREET 1: 1616 EASTLAKE AVE. E
STREET 2: SUITE 310
CITY: SEATTLE
STATE: WA
ZIP: 98102
FORMER COMPANY:
FORMER CONFORMED NAME: VACCSYS INC
DATE OF NAME CHANGE: 20080617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-04
0
0001437786
Immune Design Corp.
IMDZ
0001185858
BALTIMORE DAVID
C/O IMMUNE DESIGN CORP.
1616 EASTLAKE AVE. E., SUITE 310
SEATTLE
WA
98102
1
0
0
0
Stock Option (right to buy)
4.05
2018-01-04
4
A
0
12500
0.00
A
2028-01-04
Common Stock
12500
12500
D
All shares underlying the option will vest on January 4, 2019.
/s/ Stephen R. Brady, Attorney-In-Fact
2018-01-08